open access

Vol 91, No 10 (2020)
Guidelines / Expert consensus
Published online: 2020-10-30
Get Citation

Polish Society of Gynecologists and Obstetricians Recommendations on diagnosis and management of fetal growth restriction

Sebastian Kwiatkowski, Andrzej Torbe, Dariusz Borowski, Grzegorz Breborowicz, Krzysztof Czajkowski, Hubert Huras, Anna Kajdy, Jaroslaw Kalinka, Katarzyna Kosinska-Kaczynska, Bozena Leszczynska-Gorzelak, Wojciech Rokita, Mariola Ropacka-Lesiak, Piotr Sieroszewski, Miroslaw Wielgos, Mariusz Zimmer
DOI: 10.5603/GP.2020.0158
·
Pubmed: 33184833
·
Ginekol Pol 2020;91(10):634-643.

open access

Vol 91, No 10 (2020)
RECOMMENDATIONS
Published online: 2020-10-30

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Polish Society of Gynecologists and Obstetricians Recommendations on diagnosis and management of fetal growth restriction

Journal

Ginekologia Polska

Issue

Vol 91, No 10 (2020)

Article type

Guidelines / Expert consensus

Pages

634-643

Published online

2020-10-30

DOI

10.5603/GP.2020.0158

Pubmed

33184833

Bibliographic record

Ginekol Pol 2020;91(10):634-643.

Authors

Sebastian Kwiatkowski
Andrzej Torbe
Dariusz Borowski
Grzegorz Breborowicz
Krzysztof Czajkowski
Hubert Huras
Anna Kajdy
Jaroslaw Kalinka
Katarzyna Kosinska-Kaczynska
Bozena Leszczynska-Gorzelak
Wojciech Rokita
Mariola Ropacka-Lesiak
Piotr Sieroszewski
Miroslaw Wielgos
Mariusz Zimmer

References (34)
  1. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics and the Society forMaternal-FetalMedicin. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstet Gynecol. 2019; 133(2): e97–e9e109.
  2. Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol. 2011; 204(4): 288–300.
  3. Ganzevoort W, Thornton JG, Marlow N, et al. GRIT Study Group, TRUFFLE Study Group. Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials. Ultrasound Obstet Gynecol. 2020; 55(1): 68–74.
  4. Lees CC, Marlow N, van Wassenaer-Leemhuis A, et al. TRUFFLE study group. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet. 2015; 385(9983): 2162–2172.
  5. Lees C, Marlow N, Arabin B, et al. TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013; 42(4): 400–408.
  6. Hepburn M, Rosenberg K. An audit of the detection and management of small-for-gestational age babies. Br J Obstet Gynaecol. 1986; 93(3): 212–216.
  7. Backe B, Nakling J. Effectiveness of antenatal care: a population based study. Br J Obstet Gynaecol. 1993; 100(8): 727–732.
  8. Pietryga M, Borowski D, Brązert J, et al. Rekomendacje Sekcji Ultrasonografii Polskiego Towarzystwa Ginekologicznego w zaskresie przesiewowej diagnostyki ultrasonograficznej w ciąży o przebiegu - 2015r. Ginekol Pol. 2015; 86(7): 551–559.
  9. Rozporządzenie Ministra Zdrowia z dnia 16 sierpnia 2018 r. w sprawie standardu organizacyjnego opieki okołoporodowej. Dziennik Ustaw Rzeczpospolitej Polskiej poz. 1756.
  10. Kajdy A, Modzelewski J, Jakubiak M, et al. Effect of antenatal detection of small-for-gestational-age newborns in a risk stratified retrospective cohort. PLoS One. 2019; 14(10): e0224553.
  11. Ego A, Zeitlin J, Batailler P, et al. Stillbirth classification in population-based data and role of fetal growth restriction: the example of RECODE. BMC Pregnancy Childbirth. 2013; 13: 182.
  12. Gardosi J, Giddings S, Clifford S, et al. Association between reduced stillbirth rates in England and regional uptake of accreditation training in customised fetal growth assessment. BMJ Open. 2013; 3(12): e003942.
  13. The Investigation and Management of the Small–for–Gestational–Age Fetus. RCOG Green–top Guideline No. 31: 1–34.
  14. Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol. 2017; 216(2): 110–120.e6.
  15. Wojtyła A, Goździewska M, Paprzycki P, et al. Tobacco-related Foetal Origin of Adult Diseases Hypothesis--population studies in Poland. Ann Agric Environ Med. 2012; 19(1): 117–128.
  16. Salomon LJ, Alfirevic Z, Da Silva Costa F, et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol. 2019; 53(6): 715–723.
  17. Dall'Asta A, Girardelli S, Usman S, et al. Etiology and perinatal outcome of periviable fetal growth restriction associated with structural or genetic anomaly. Ultrasound Obstet Gynecol. 2020; 55(3): 368–374.
  18. Peyron F, L'ollivier C, Mandelbrot L, et al. Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group. Pathogens. 2019; 8(1).
  19. Conner SN, Longman RE, Cahill AG. The role of ultrasound in the diagnosis of fetal genetic syndromes. Best Pract Res Clin Obstet Gynaecol. 2014; 28(3): 417–428.
  20. Buck Louis GM, Grewal J, Albert PS, et al. Racial/ethnic standards for fetal growth: the NICHD Fetal Growth Studies. Am J Obstet Gynecol. 2015; 213(4): 449.e1–449.e41.
  21. Gorstein J, Sullivan K, Yip R, et al. Issues in the assessment of nutritional status using anthropometry. Bull World Health Organ. 1994; 72(2): 273–283.
  22. Gardosi J. Customised assessment of fetal growth potential: implications for perinatal care. Arch Dis Child Fetal Neonatal Ed. 2012; 97(5): F314–F317.
  23. Gardosi J. Counterpoint. Am J Obstet Gynecol. 2019; 220(1): 74–82.
  24. Lausman A, Kingdom J, Gagnon R, et al. Intrauterine Growth Restriction: Screening, Diagnosis, and Management. J Obstet Gynaecol Can. 2013; 35(8): 741–748.
  25. Beune IM, Damhuis SE, Ganzevoort W, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol. 2016; 48(3): 333–339.
  26. Baschat AA. Planning management and delivery of the growth-restricted fetus. Best Pract Res Clin Obstet Gynaecol. 2018; 49: 53–65.
  27. Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014; 36(2): 86–98.
  28. Caradeux J, Martinez-Portilla RJ, Basuki TR, et al. Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis. Am J Obstet Gynecol. 2018; 218(2S): S774–S782.e21.
  29. Ebbing C, Acharya G, Sitras V, Helbig A, Husby H. Intrauterine growth restriction. Approved by the Norwegian Society of Obstetrics and Gynecology, June 2016.
  30. Vintzileos AM, Smulian JC. Decelerations, tachycardia, and decreased variability: have we overlooked the significance of longitudinal fetal heart rate changes for detecting intrapartum fetal hypoxia? Am J Obstet Gynecol. 2016; 215(3): 261–264.
  31. Martin A. [Fetal heart rate during labour: definitions and interpretation]. J Gynecol Obstet Biol Reprod (Paris). 2008; 37 Suppl 1: S34–S45.
  32. Postępowanie w nadciśnieniu tętniczym u kobiet w ciąży. Postępowanie w nadciśnieniu tętniczym u kobiet w ciąży. Zapobieganie, diagnostyka, leczenie i odległe rokowanie Stanowisko Polskiego Towarzystwa Nadciśnienia Tętniczego, Polskiego Towarzystwa Kardiologicznego oraz Polskiego Towarzystwa Ginekologów i Położników. Ginekol Perinatol Prakt. 2019; 4(2): 43–111.
  33. Bomba-Opoń D, Drews K, Huras H, et al. Polish Gynecological Society Recommendations for Labor Induction. Ginekol Pol. 2017; 88(4): 224–234.
  34. Boers KE, Vijgen SMC, Bijlenga D, et al. DIGITAT study group. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ. 2010; 341: c7087.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl